{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:51:32Z","timestamp":1791157892645,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":110,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10492-6","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:34:11Z","timestamp":1781699651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Whole \u03b2-glucan particles modulate BCG-induced macrophage and CD4+ T-cell responses via the Dectin-1\u2013JAK1\/STAT1 pathway"],"prefix":"10.1038","volume":"9","author":[{"given":"Yige","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-9381","authenticated-orcid":false,"given":"Xiao-lian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4210-2852","authenticated-orcid":false,"given":"Qin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7095-1344","authenticated-orcid":false,"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"10492_CR1","unstructured":"World Health O. Global Tuberculosis Report 2024 (World Health Organization, 2024)."},{"key":"10492_CR2","volume":"386","author":"EB Hook","year":"2022","unstructured":"Hook, E. B. Latent Tuberculosis Infection. N. Engl. J. Med. 386, e33 (2022).","journal-title":"N. Engl. J. Med."},{"key":"10492_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1473-3099(15)00400-4","volume":"16","author":"P Nguipdop-Djomo","year":"2016","unstructured":"Nguipdop-Djomo, P., Heldal, E., Rodrigues, L. C., Abubakar, I. & Mangtani, P. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study. Lancet Infect. Dis. 16, 219\u2013226 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"10492_CR4","doi-asserted-by":"publisher","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","volume":"8","author":"A Zwerling","year":"2011","unstructured":"Zwerling, A. et al. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 8, e1001012 (2011).","journal-title":"PLoS Med."},{"key":"10492_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.747799","volume":"13","author":"F Ahmad","year":"2022","unstructured":"Ahmad, F. et al. Macrophage: a cell with many faces and functions in tuberculosis. Front Immunol. 13, 747799 (2022).","journal-title":"Front Immunol."},{"key":"10492_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05683-w","volume":"22","author":"Q Lei","year":"2024","unstructured":"Lei, Q. et al. Early introduction of IL-10 weakens BCG revaccination\u2019s protection by suppressing CD4(+)Th1 cell responses. J. Transl. Med. 22, 1103 (2024).","journal-title":"J. Transl. Med."},{"key":"10492_CR7","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.4049\/jimmunol.1201061","volume":"189","author":"JM Pitt","year":"2012","unstructured":"Pitt, J. M. et al. Blockade of IL-10 signaling during BCG vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-\u03b3 and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. J. Immunol. 189, 4079\u20134087 (2012).","journal-title":"J. Immunol."},{"key":"10492_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","volume":"58","author":"P Mangtani","year":"2014","unstructured":"Mangtani, P. et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin. Infect. Dis. 58, 470\u2013480 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"10492_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cell.2004.11.038","volume":"119","author":"MG Gutierrez","year":"2004","unstructured":"Gutierrez, M. G. et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753\u2013766 (2004).","journal-title":"Cell"},{"key":"10492_CR10","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1073\/pnas.0409716102","volume":"102","author":"I Vergne","year":"2005","unstructured":"Vergne, I. et al. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 102, 4033\u20134038 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10492_CR11","doi-asserted-by":"publisher","first-page":"19371","DOI":"10.1073\/pnas.1109201108","volume":"108","author":"D Wong","year":"2011","unstructured":"Wong, D., Bach, H., Sun, J., Hmama, Z. & Av-Gay, Y. Mycobacterium tuberculosis protein tyrosine phosphatase (PtpA) excludes host vacuolar-H+-ATPase to inhibit phagosome acidification. Proc. Natl. Acad. Sci. USA 108, 19371\u201319376 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10492_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109030","volume":"27","author":"CJH Horneck Johnston","year":"2024","unstructured":"Horneck Johnston, C. J. H. et al. Recognition of yeast \u03b2-glucan particles triggers immunometabolic signaling required for trained immunity. iScience 27, 109030 (2024).","journal-title":"iScience"},{"key":"10492_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126440","volume":"252","author":"B Xiong","year":"2023","unstructured":"Xiong, B. et al. Actinidia eriantha polysaccharide exerts adjuvant activity by targeting linc-AAM. Int. J. Biol. Macromol. 252, 126440 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"10492_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12833","volume":"91","author":"V Vetvicka","year":"2020","unstructured":"Vetvicka, V., Vannucci, L. & Sima, P. \u03b2-glucan as a new tool in vaccine development. Scand. J. Immunol. 91, e12833 (2020).","journal-title":"Scand. J. Immunol."},{"key":"10492_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/143524","volume":"2012","author":"ER Soto","year":"2012","unstructured":"Soto, E. R., Caras, A. C., Kut, L. C., Castle, M. K. & Ostroff, G. R. Glucan particles for macrophage targeted delivery of nanoparticles. J. Drug Deliv. 2012, 143524 (2012).","journal-title":"J. Drug Deliv."},{"key":"10492_CR16","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.4049\/jimmunol.1501853","volume":"196","author":"SH Albeituni","year":"2016","unstructured":"Albeituni, S. H. et al. Yeast-derived particulate \u03b2-glucan treatment subverts the suppression of myeloid-derived suppressor cells (MDSC) by inducing polymorphonuclear MDSC apoptosis and monocytic MDSC differentiation to APC in cancer. J. Immunol. 196, 2167\u20132180 (2016).","journal-title":"J. Immunol."},{"key":"10492_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijo.2018.4630","volume":"54","author":"X Li","year":"2019","unstructured":"Li, X. et al. \u03b2\u2011glucan, a dectin\u20111 ligand, promotes macrophage M1 polarization via NF\u2011\u03baB\/autophagy pathway. Int. J. Oncol. 54, 271\u2013282 (2019).","journal-title":"Int. J. Oncol."},{"key":"10492_CR18","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s00262-021-03136-7","volume":"71","author":"L He","year":"2022","unstructured":"He, L. et al. Oral administration of a whole glucan particle (WGP)-based therapeutic cancer vaccine targeting macrophages inhibits tumor growth. Cancer Immunol. Immunother. 71, 2007\u20132028 (2022).","journal-title":"Cancer Immunol. Immunother."},{"key":"10492_CR19","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.cclet.2021.01.035","volume":"32","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Alum colloid encapsulated inside \u03b2-glucan particles enhance humoral and CTL immune responses of MUC1 vaccine. Chin. Chem. Lett. 32, 1963\u20131966 (2021).","journal-title":"Chin. Chem. Lett."},{"key":"10492_CR20","doi-asserted-by":"crossref","unstructured":"Hung, C. Y. et al. Glucan-chitin particles enhance Th17 response and improve protective efficacy of a multivalent antigen (rCpa1) against pulmonary Coccidioides posadasii Infection. Infect. Immun. 86, e00070-18 (2018).","DOI":"10.1128\/IAI.00070-18"},{"key":"10492_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2024.110238","volume":"333","author":"H Mao","year":"2025","unstructured":"Mao, H. et al. The effect of \u03b2-Glucan induced intestinal trained immunity against Trichinella spiralis infection. Vet. Parasitol. 333, 110238 (2025).","journal-title":"Vet. Parasitol."},{"key":"10492_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fimmu.2018.00225","volume":"9","author":"M Wagener","year":"2018","unstructured":"Wagener, M., Hoving, J. C., Ndlovu, H. & Marakalala, M. J. Dectin-1-Syk-CARD9 signaling pathway in TB immunity. Front Immunol. 9, 225 (2018).","journal-title":"Front Immunol."},{"key":"10492_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/ni.1692","volume":"10","author":"SI Gringhuis","year":"2009","unstructured":"Gringhuis, S. I. et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-\u03baB activation through Raf-1 and Syk. Nat. Immunol. 10, 203\u2013213 (2009).","journal-title":"Nat. Immunol."},{"key":"10492_CR24","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1182\/blood-2006-05-024406","volume":"108","author":"M Yadav","year":"2006","unstructured":"Yadav, M. & Schorey, J. S. The \u03b2-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 108, 3168\u20133175 (2006).","journal-title":"Blood"},{"key":"10492_CR25","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.230315","volume":"14","author":"A Kunanopparat","year":"2024","unstructured":"Kunanopparat, A. et al. Complement receptor 3-dependent engagement by Candida glabrata \u03b2-glucan modulates dendritic cells to induce regulatory T-cell expansion. Open Biol. 14, 230315 (2024).","journal-title":"Open Biol."},{"key":"10492_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ijbiomac.2022.02.111","volume":"205","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. The phagocytic receptors of \u03b2-glucan. Int. J. Biol. Macromol. 205, 430\u2013441 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"10492_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3389\/fimmu.2020.00658","volume":"11","author":"B Han","year":"2020","unstructured":"Han, B., Baruah, K., Cox, E., Vanrompay, D. & Bossier, P. Structure-functional activity relationship of \u03b2-glucans from the perspective of immunomodulation: a mini-review. Front Immunol. 11, 658 (2020).","journal-title":"Front Immunol."},{"key":"10492_CR28","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1172\/JCI134778","volume":"130","author":"G Camilli","year":"2020","unstructured":"Camilli, G. et al. \u03b2-Glucan-induced reprogramming of human macrophages inhibits NLRP3 inflammasome activation in cryopyrinopathies. J. Clin. Invest 130, 4561\u20134573 (2020).","journal-title":"J. Clin. Invest"},{"key":"10492_CR29","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.4049\/jimmunol.169.7.3876","volume":"169","author":"PR Taylor","year":"2002","unstructured":"Taylor, P. R. et al. The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte\/macrophage and neutrophil lineages. J. Immunol. 169, 3876\u20133882 (2002).","journal-title":"J. Immunol."},{"key":"10492_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4110\/in.2011.11.4.191","volume":"11","author":"HS Kim","year":"2011","unstructured":"Kim, H. S., Hong, J. T., Kim, Y. & Han, S. B. Stimulatory effect of \u03b2-glucans on immune cells. Immune Netw. 11, 191\u2013195 (2011).","journal-title":"Immune Netw."},{"key":"10492_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2016).","journal-title":"Science"},{"key":"10492_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-68466-5","volume":"17","author":"F Hamdan","year":"2026","unstructured":"Hamdan, F. et al. Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response. Nat. Commun. 17, 1757 (2026).","journal-title":"Nat. Commun."},{"key":"10492_CR33","doi-asserted-by":"publisher","first-page":"e0323376","DOI":"10.1371\/journal.pone.0323376","volume":"20","author":"J Ajit","year":"2025","unstructured":"Ajit, J. et al. \u03b2-glucan induced trained immunity enhances antibody levels in a vaccination model in mice. PLoS ONE 20, e0323376 (2025).","journal-title":"PLoS ONE"},{"key":"10492_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28407-4","volume":"13","author":"AE Geller","year":"2022","unstructured":"Geller, A. E. et al. The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression. Nat. Commun. 13, 759 (2022).","journal-title":"Nat. Commun."},{"key":"10492_CR35","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1021\/acs.jmedchem.7b01598","volume":"61","author":"ML Vazquez","year":"2018","unstructured":"Vazquez, M. L. et al. Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): a selective JAK1 clinical candidate for the treatment of autoimmune diseases. J. Med. Chem. 61, 1130\u20131152 (2018).","journal-title":"J. Med. Chem."},{"key":"10492_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1600-0609.2007.00968.x","volume":"79","author":"H Meng","year":"2007","unstructured":"Meng, H. et al. Antitumor activity of fludarabine against human multiple myeloma in vitro and in vivo. Eur. J. Haematol. 79, 486\u2013493 (2007).","journal-title":"Eur. J. Haematol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10492-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10492-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10492-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:02:30Z","timestamp":1791154950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10492-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10492"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10492-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1283"}}